Universal Beteiligungs und Servicegesellschaft mbH Has $36.34 Million Stock Position in Cardinal Health, Inc. $CAH

Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 216,327 shares of the company’s stock after acquiring an additional 10,170 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Cardinal Health were worth $36,343,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the business. Geode Capital Management LLC lifted its position in shares of Cardinal Health by 3.3% in the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after purchasing an additional 205,539 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares during the last quarter. Northern Trust Corp lifted its position in Cardinal Health by 3.5% during the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock worth $433,012,000 after buying an additional 105,154 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after buying an additional 2,249,241 shares during the last quarter. Finally, Acadian Asset Management LLC grew its holdings in shares of Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after acquiring an additional 807,063 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Insider Transactions at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the transaction, the chief executive officer directly owned 200,000 shares of the company’s stock, valued at $30,008,000. This represents a 15.22% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.12% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the company a “buy” rating in a research report on Monday, November 3rd. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Mizuho upped their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. Twelve investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $206.46.

Cardinal Health Price Performance

NYSE:CAH opened at $206.25 on Tuesday. The company has a market cap of $49.00 billion, a P/E ratio of 31.98, a P/E/G ratio of 1.39 and a beta of 0.72. The firm’s fifty day moving average price is $166.70 and its two-hundred day moving average price is $159.64. Cardinal Health, Inc. has a one year low of $114.60 and a one year high of $208.32.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. During the same quarter last year, the company posted $1.88 EPS. Cardinal Health’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.